Cookson Peirce & Co’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,000
Closed -$558K – 364
2026
Q2
$558K Buy
+23,000
New +$392K 0.02% 244

Other funds holding NRIX

Cookson Peirce & Co's NRIX Position: Q3 2026 in Review

Cookson Peirce & Co sold out of Nurix Therapeutics (NRIX) in Q3 2026, closing a stake of 23,000 shares — an estimated $558K sold.

Cookson Peirce & Co first reported a position in NRIX in Q2 2026 and held it in 1 quarter. The position peaked at $558K in Q2 2026. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Cookson Peirce & Co reported no remaining Nurix Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Cookson Peirce & Co sold 23,000 Nurix Therapeutics shares in Q3 2026, an estimated $558K.
  • Cookson Peirce & Co first reported a position in Nurix Therapeutics in Q2 2026 and held it in 1 quarter.
  • Cookson Peirce & Co's Nurix Therapeutics position peaked at $558K in Q2 2026.
  • 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.